Nisa Investment Advisors LLC Makes New Investment in Ralliant Corporation $RAL

Nisa Investment Advisors LLC purchased a new stake in Ralliant Corporation (NYSE:RAL) in the 3rd quarter, according to its most recent filing with the SEC. The fund purchased 20,843 shares of the company’s stock, valued at approximately $911,000.

Several other hedge funds have also made changes to their positions in the business. Dodge & Cox purchased a new stake in shares of Ralliant in the second quarter valued at $523,571,000. Viking Global Investors LP acquired a new stake in Ralliant in the 2nd quarter worth about $257,200,000. State Street Corp purchased a new stake in Ralliant in the 2nd quarter valued at about $213,096,000. Flossbach Von Storch SE acquired a new position in shares of Ralliant during the 2nd quarter valued at about $198,077,000. Finally, Norges Bank purchased a new position in shares of Ralliant during the 2nd quarter worth about $108,453,000.

Wall Street Analysts Forecast Growth

RAL has been the subject of a number of recent analyst reports. Royal Bank Of Canada boosted their target price on shares of Ralliant from $45.00 to $52.00 and gave the company a “sector perform” rating in a report on Friday, November 7th. Citigroup upgraded shares of Ralliant from a “neutral” rating to a “buy” rating and lifted their price target for the company from $53.00 to $61.00 in a report on Monday, December 8th. Barclays upped their price objective on Ralliant from $59.00 to $60.00 and gave the stock an “overweight” rating in a report on Wednesday, January 7th. Oppenheimer increased their target price on Ralliant from $55.00 to $60.00 and gave the stock an “outperform” rating in a research report on Monday, December 15th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Ralliant in a research report on Monday, December 29th. Six equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, Ralliant currently has an average rating of “Moderate Buy” and an average target price of $58.00.

Ralliant Stock Up 2.7%

Ralliant stock opened at $53.95 on Friday. The stock has a fifty day simple moving average of $49.98. Ralliant Corporation has a 52-week low of $40.70 and a 52-week high of $55.08. The company has a quick ratio of 1.03, a current ratio of 1.49 and a debt-to-equity ratio of 0.39. The firm has a market capitalization of $6.09 billion and a price-to-earnings ratio of 42.48.

Ralliant (NYSE:RAL) last posted its earnings results on Wednesday, November 5th. The company reported $0.60 earnings per share for the quarter, beating the consensus estimate of $0.58 by $0.02. The business had revenue of $529.10 million for the quarter, compared to analyst estimates of $519.14 million. Ralliant has set its Q4 2025 guidance at 0.620-0.680 EPS.

Ralliant Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 23rd. Stockholders of record on Monday, December 8th were paid a $0.05 dividend. The ex-dividend date was Monday, December 8th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.4%. Ralliant’s dividend payout ratio (DPR) is 15.75%.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.